Embold Health, founded in 2017, is a US-based startup that aims to improve health outcomes and reduce costs for employees by providing insights into provider quality. With a focus on analytics and healthcare, the company leverages a vast dataset, clinically validated analytics, and the expertise of leading physicians and data scientists to highlight top-performing doctors. This ensures that individuals receive better care while offering all doctors the chance to enhance their practices. The company's transparent solution not only empowers employers, health plans, and physicians to make informed decisions but also invites them to participate in the transformation of healthcare. Embold Health's recent milestone includes a noteworthy Series B investment of $23.00M secured on 16 March 2022. The investment was led by Chrysalis Ventures, Echo Health Ventures, Whistler Capital Partners, and Morgan Health. With its strong value proposition and backing from prominent investors, Embold Health is well-positioned to make a significant impact in the analytics and healthcare industries.
No recent news or press coverage available for Embold Health.